U.S. Food and Drug Administration Science Forum Home Go to Abstract list by Category Go to Abstract list by Author Go to Abstract Search
FDA Science, A Century of FDA Science: Pioneering The Future of Public Health, 12th Annual FDA Science Forum, April 18-20, 2006
Abstract Search
 
<< Back to Abstract Listing by Author

Board Number: G-16
Title: Interchangeability of the two measurement systems of the anthrax vaccine potency: Toxin Neutralization Assay and ELISA.

L. A. Sirota 1 , B. G. Zaslavsky 1 , P. M. Parreiras 2 , L. D. Wagner 1 , S. L. Menzies 1 , J. L. Arciniega 1 , 1 CBER, FDA, Rockville MD 20852 , 2 NIQCH, Rio de Janeiro, RJ 21.040-900 - Brazil
                   

Correlation analysis, analysis of covariance, and the Altman-Bland empirical method have been used to elucidate the relationship between antigen-specific ELISA and a lethal toxin neutralization assay (TNA) of anthrax vaccine potency measurements. Both assays measure the antibody response to Protective Antigen (PA) in mice immunized once with either Anthrax Vaccine Adsorbed (AVA) or an in-house recombinant PA vaccine (rPAV) at various doses.

 

Coefficients of correlation and linear regression equations for the two assays were found to be immunization dose dependent. ELISA and TNA results may not be strictly interchangeable for this animal model.  Further experiments are needed to study the biological mechanisms underlying the relationships found between the assays and to understand the meaning and relevance of these results for vaccine-testing purposes.


Category: G. Biostatistics and Design and Evaluation Of Clinical Trials